NewTimeSpace News: On 21 July 2026, BIDU-SW(09888.HK) saw sluggish performance during morning trading. As of 11:18 a.m., the stock traded at HK$106.10, down 2.84%. Apollo Go and TPH signed a strategic cooperation agreement in Shanghai to jointly launch autonomous vehicle mobility services in Kazakhstan.
The Enterprise AI Summit Shanghai 2026 highlighted that the primary hurdle in enterprise AI deployment is "cognitive misalignment," not technology. Enterprise procurement is fundamentally shifting from buying "chatting AI" to acquiring "result-delivering Agents," moving from IT-led to business-led purchasing with a strict focus on quantifiable ROI. The summit emphasized that organizational readiness—such as direct executive leadership, clear validation of business value, and converting implicit knowledge into digital assets—is far more critical than raw model capabilities. To scale from "usable" to "trustworthy," AI must be deeply embedded into workflows to deliver auditable and replicable commercial outcomes.
NewTimeSpace News: SSY GROUP (02005.HK) announced that its gadobutrol active pharmaceutical ingredient (API) has obtained registration approval from the National Medical Products Administration (NMPA) for use in marketed finished pharmaceutical products. As an MRI contrast agent, gadobutrol is indicated for adults and paediatric patients of all ages, applied in contrast-enhanced MRI and MR angiography examinations for lesions across all body parts.
On July 20, Hong Kong stocks rebounded, while the LLM sector exhibited sharp structural divergence. Shares tied to embodied AI and agent implementation surged, with XUNCE and SenseTime rising, and Chinasoft International skyrocketing 23% following a Token partnership with Moonshot AI; conversely, pure-play LLMs like ZHIPU AI and MiniMax continued their slide. On the corporate front, Moonshot AI sent IPO proposals aiming for a Hong Kong listing within six months as ARR reached USD 300 million; Tencent launched a standalone App for its efficiency agent WorkBuddy; and China Renaissance initiated coverage on Mininglamp, praising its Agentic AI monetization. The sector is accelerating its pivot toward commercialization and ecosystem monetization.
NewTimeSpace (newtimespace.com) reported that on July 20, 2026, the semiconductor theme in Hong Kong stocks rebounded with volatility, and HUA HONG GRACE (01347.HK) rose in choppy trading. As of 13:30, the stock was quoted at HKD 142.500, up 2.74%.
NewTimeSpace (newtimespace.com) reported that on July 20, 2026, the humanoid robot theme fluctuated weaker, while Midea Group(00300.HK) fluctuated higher. As of 13:19, the stock was quoted at HKD 94.250, up 2.17%.
NewTimeSpace News: ZHAOKE OPHTH-B (06622.HK) announced that YUVEZZI™ (2.75% carbachol & 0.1% brimonidine tartrate ophthalmic solution), its innovative drug for presbyopia, was approved by the Macao Special Administrative Region Government Drug Administration on 13 July 2026. The Group is actively applying for YUVEZZI™ to be included in the Hong Kong-Macao Medicines & Devices Connect Scheme to accelerate its clinical application in the Greater Bay Area.
NewTimeSpace News: On 20 July 2026, RoboSense (02498.HK) posted a mild uptick during morning trading. As of 11:19 a.m., the stock traded at HK$22.04, representing a 0.82% gain. The second-generation all-solid-state perception platform E2, built on the self-developed "Peacock" SPAD-SoC chip, was launched at WAIC 2026.
NewTimeSpace (newtimespace.com) News,Choice data shows that from the beginning of July 2026 to July 17,Huaan Hang Seng Internet Technology Industry ETF Initiating Feeder Fund A (019936) and Huaan Hang Seng Internet Technology Industry ETF Initiating Feeder Fund C (019937) rose by 8.60% and 8.59%, respectively.
NewTimeSpace (newtimespace.com) News, Choice data shows that from the beginning of July 2026 to July 17,ChinaAMC Hang Seng Internet Technology Industry ETF Initiating Feeder Fund A (013171) andChinaAMC Hang Seng Internet Technology Industry ETF Initiating Feeder Fund C (013172) rose by 8.60% and 8.72%, respectively.
NewTimeSpace News: CSTONE PHARMA-B (02616.HK) announced on 20 July that clinical data of its core asset CS2009, a first-in-class PD-1/VEGF/CTLA-4 trispecific antibody, has been accepted by ESMO Congress 2026 for two rapid oral presentations covering Phase I/II trial results in advanced NSCLC and metastatic colorectal cancer patients. Updated full data will be unveiled at the Madrid conference held from 23 to 26 October 2026. The Company reminds investors of uncertainties in the clinical development and commercialization of CS2009.
NewTimeSpace News: IMPACT THERAP-B (07630.HK) announced on 20 July that clinical data of three pipeline assets, namely senaparib, IMP1734 and IMP1707, have been accepted as poster presentations for the ESMO Congress 2026. Senaparib has been approved in China for first-line maintenance therapy of advanced ovarian cancer and included in the national medical insurance catalogue, with its European MAA filed and accepted by EMA. IMP1734 and IMP1707 are next-generation selective PARP1 inhibitors.
NewTimeSpace News: JACOBIO-B (01167.HK) announced on 20 July that its pan-KRAS inhibitor JAB-23E73 combined with nab-paclitaxel and gemcitabine completed first patient dosing in China for a Phase Ib/III clinical trial as first-line therapy for KRAS-mutant pancreatic cancer. Earlier Phase I data showed an ORR of 38.5% with favourable safety profile. AstraZeneca has obtained exclusive global rights (excluding mainland China), where the two parties co-develop and co-commercialise the candidate. The Company cautions uncertainties exist in drug development.
NewTimeSpace News: CanSino Biologics announced on 19 July that the Company has received an Acceptance Notice issued by the National Medical Products Administration (NMPA), confirming the acceptance of the supplementary application for the ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (MCV4, trade name: Menhyxin®).
This week, Hong Kong's LLM sector experienced extreme divergence, culminating in a Friday crash. Tech giants with resilient core businesses—such as Meituan and Alibaba—advanced, driven by Agent deployment and AI coding market dominance. Conversely, pure-play LLMs like ZHIPU AI and MiniMax suffered severe weekly losses due to lock-up expiration panic and high-valuation fragility. Despite capital market volatility, industry fundamentals strengthened significantly across infrastructure and global governance: 29 nations signed the WAICO agreement in Shanghai; DeepSeek's valuation reached RMB 351 billion; Moonshot AI launched the 2.8-trillion-parameter Kimi K3; and Tencent's Hy3 topped global API volumes. The sector is accelerating its transition toward an industrialized phase emphasizing both robust compute infrastructure and commercial monetization.
On July 16, 2026, YoulianCloud (GEOPlus) won the "AI Native Product Award" at the 7th Unique Awards for its innovative practices in financial GEO. As regulators accelerate AI integration into capital markets and leading securities firms establish computing power moats, financial AI is entering a new stage of institutional standardization. With China's generative AI user base surpassing 600 million and information retrieval shifting toward conversational AI, GEOPlus serves as a core infrastructure. Leveraging its advantages in technology, content, industry, and compliance, it provides full-process, closed-loop financial GEO services for asset managers and listed companies, building proprietary knowledge bases to reshape the communication landscape of secondary market capital value.
